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The formation of the nervous system is initiated when ectodermal cells adopt the neural fate. Studies in Xenopus demonstrate that inhibition of
BMP results in the formation of neural tissue. However, the molecular mechanism driving the expression of early neural genes in response to this
inhibition is unknown. Moreover, controversy remains regarding the sufficiency of BMP inhibition for neural induction. To address these questions,
we performed a detailed analysis of the regulation of the soxB1 gene, sox3, one of the earliest genes expressed in the neuroectoderm. Using
ectodermal explant assays, we analyzed the role of BMP, Wnt and FGF signaling in the regulation of sox3 and the closely related soxB1 gene, sox2.
Our results demonstrate that both sox3 and sox2 are induced in response to BMP antagonism, but by distinct mechanisms and that the activation of
both genes is independent of FGF signaling. However, both require FGF for the maintenance of their expression. Finally, sox3 genomic elements
were identified and characterized and an element required for BMP-mediated repression via Vent proteins was identified through the use of
transgenesis and computational analysis. Interestingly, none of the elements required for sox3 expression were identified in the sox2 locus. Together
our data indicate that two closely related genes have unique mechanisms of gene regulation at the onset of neural development.
© 2007 Elsevier Inc. All rights reserved.Keywords: Neural induction; Xenopus laevis; Gene regulation; Neural induction; Sox2; Sox3; BMP; FGF; VentIntroduction
The molecular mechanism of neural induction in vertebrates
has yet to be defined as evidence supports both the neural default
and the instructive signaling models. The neural default model
states that neural tissue is formed when the epidermal-inducing
factor BMP (bone morphogenetic protein) is absent (Hawley
et al., 1995; Weinstein and Hemmati-Brivanlou, 1997; Wilson
and Hemmati-Brivanlou, 1995). Indeed, Spemann's organizer
releases antagonists of BMP such as Noggin (Zimmerman et al.,
1996), Chordin (Piccolo et al., 1996) and Follistatin (Fainsod
et al., 1997), each capable of inhibiting BMP signaling. While
this model stemmed from work in amphibians, studies in mouse
and human embryonic stem cells suggest that BMP regulates⁎ Corresponding author. Fax: +1 202 687 5662.
E-mail address: emc26@georgetown.edu (E.M. Silva Casey).
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doi:10.1016/j.ydbio.2007.10.023ectodermal fate signaling in disparate species (Pera et al., 2004;
Tropepe et al., 2001; Vallier et al., 2004; Ying et al., 2003). In
contrast, the instructive signaling model, while not disputing a
role for BMP inhibition in neural induction, posits that BMP
inhibition may not be sufficient for neural induction. The
observation in chick that the temporal expression of BMP
inhibitors does not correspond to the timing of neural induction
and that BMP antagonists alone were not capable of inducing
neural tissue outside of the presumptive neural plate suggest that
other signals may also play a role in neural induction (Linker and
Stern, 2004; Streit et al., 2000, 1998; Streit and Stern, 1999).
Two candidate signaling pathways are Wnt and FGF (Fibroblast
Growth Factor).
In both frogs and chick, Wnt signaling affects the fate of
ectodermal cells by altering the level of BMP expression and
signaling. In Xenopus, activation of maternal Wnt signaling
leads to the down-regulation of BMP expression thereby
neuralizing ectodermal tissue non-cell autonomously (Baker
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2001). Interestingly, recent work suggests that β-catenin with
Tcf3 inhibits the expression of early neural markers in a cell-
autonomous fashion in Xenopus (Heeg-Truesdell and
Labonne, 2006), thus complementing studies in chick
demonstrating that Wnt signaling promotes BMP signaling
and epidermal formation by decreasing responsiveness to FGF
(Wilson et al., 2001).
FGF signaling has multiple roles in neural development. In
chick, FGF has the dual role of blocking BMP signaling and
independently promoting neural differentiation (Streit et al.,
2000; Wilson et al., 2000). In ascidians, FGF signaling is the
predominant mechanism of neural induction with BMP
antagonism only playing a role later in development (Bertrand
et al., 2003; Darras and Nishida, 2001; Hudson et al., 2003;
Lemaire et al., 2002). In contrast, in frogs and fish, FGF has an
uncertain role in neural induction and its primary role may be
inhibition of BMP signaling (Furthauer et al., 1997; Kuroda
et al., 2005; Pera et al., 2003). While the exact role of FGF and
Wnt in neural induction is still controversial, these studies
demonstrate that a complex integration of these pathways is
required to maintain and pattern neural tissue.
A response to neural induction is conserved across
vertebrates: the expression of the early neural genes sox2 and
sox3 in the neuroectoderm. Sox2 and Sox3 are members of
the SoxB1 (Sox1, 2, and 3) subgroup of HMG-box transcrip-
tion factors. These genes share remarkable sequence similarity
and are expressed in the neuroectoderm at the time of neural
induction (Bowles et al., 2000; Hardcastle and Papalopulu,
2000; Mizuseki et al., 1998; Pevny et al., 1998; Rex et al.,
1997; Uchikawa et al., 1999; Uwanogho et al., 1995; Wood and
Episkopou, 1999). Sox2 is well studied in Xenopus (Kishi et
al., 2000; Mizuseki et al., 1998) and in mouse (Avilion et al.,
2003; Graham et al., 2003; Rizzoti et al., 2004). Evidence
indicates that Sox2 is required for neural formation and the
maintenance of a neural progenitor/stem cell population
(Graham et al., 2003; Taranova et al., 2006). Furthermore,
extensive analysis of SOX2 regulation in chick revealed
multiple, highly conserved enhancer modules one of which
drives expression in the neural plate (Uchikawa et al., 2003).
Analysis of this 56 bp enhancer indicates that both FGF and
Wnt signaling are required to directly initiate expression of
SOX2 (Takemoto et al., 2006).
In contrast, little has been reported on the function and
regulation of sox3. In mouse, functional studies have uncovered
roles in sex determination and pituitary formation (Laumonnier
et al., 2002; Rizzoti et al., 2004) and expression studies in
mouse of mSox3 identified anterior and posterior neural
enhancers which also drove expression in the CNS of tailbud
Xenopus embryos (Brunelli et al., 2003). However, elements
driving expression in the Xenopus gastrula were not uncovered.
In this study, we examine the regulation of the early neural
gene sox3 as a means of identifying components of the neural
induction pathway in Xenopus laevis. By comparing the
regulatory mechanism of sox3 to that of its paralog sox2, we
can begin to determine if there is a globally conserved mecha-
nism for the induction of early neural genes. Here we report thefollowing results: (1) FGF is required for the maintenance
but not the induction of sox2 and sox3 in animal caps; (2) both
genes are induced in response to inhibition of BMP, but
different regulatory proteins are required; (3) while the sox2
regulatory domains are highly conserved among vertebrates, the
sox3 regulatory regions are not and (4) the downstream effectors
of BMP signaling, Vent1 and Vent2, restrict expression of sox3
to the neural ectoderm. Thus, these data support two models of
neural induction with expression of sox3 driven by derepression
from BMP signaling while the expression of sox2 requires
instructive information.
Materials and methods
Embryo culturing and manipulations
X. laevis embryos were obtained using standard methods (Sive et al., 2000)
and staged according to Nieuwkoop and Faber (1994). Animal ectodermal
explants were isolated from stage 8–9 embryos and cultured in 0.75× Normal
Amphibian Medium (NAM) with gentamycin with or without 3.1 μg/ml
cycloheximide and 0.5 ug/ml BMP plus 0.5% BSA. Explants were collected
between stages 10.5 and 17 based on sibling embryos.
Plasmid construction
Sox3 regulatory elements were cloned by inverse PCR. The PCR fragments
were inserted into the plasmid pCR 2.1-TOPO using the TopoTA kit (Invitrogen
Corporation) and sequenced. To generate sox3-GFP, a 1.552 kb fragment
upstream of the ATG was fused to EGFP and the SV40 polyA in pCS2+ in
which the CMV promoter was removed. In the constructs with a minimal
promoter, a 90 bp minimal cytoskeletal actin promoter (Mohun and Garrett,
1987) was cloned as a blunt-HindIII fragment into the SmaI–HindIII sites of
pGL3 (Promega) in which luciferase was replaced with EGFP. Internal deletions
and binding-site mutations of sox3-GFP were generated by DPN mutagenesis.
mRNA synthesis and microinjection
Synthetic capped mRNAs were made by in vitro transcription using
mMessage mMachine kits (Ambion). For explant assays, 500 pg activinB
mRNA (Thomsen et al., 1990) or 25 pg noggin mRNA (Geng et al., 2003;
Knecht et al., 1995) was injected into the animal pole of a 1-cell embryo with
or without 0.5 ng–1 ng of dominant negative Xfrizzled-8 mRNA (ΔXfz8,
Sokol, 1996), 0.75–1.5 ng of inhibitory Xtcf-3 mRNA (ΔTcf3, Molenaar et al.,
1996), or 50–100 pg of truncated Xfgfr1 mRNA (XFD, Amaya et al., 1993).
0.7–3 ng of vent or 0.8–1.4 ng of VPvent mRNA (Onichtchouk et al., 1998)
with 250 pg of lacZ mRNA was injected into 1 of 2 cells or 0.1 ng of vent1,
vent2, and/or 0.05 ng of both was injected into 1 of 32 cells and embryos were
cultured until stage 12.5 and analyzed by whole-mount in situ hybridization
(WISH) or RT-PCR.
Transgenesis
Transgenic embryos were generated as described by Kroll and Amaya
(1993) with the following modifications: 250 ng of linearized DNA, 5 μl sperm
diluent buffer (SDB) and 3.5×104 nuclei/ml sperm nuclei are incubated with
5 μl of metaphase oocyte cytoplasm extract until nuclei decondense
(approximately 8 min). This is diluted in SDB to 70 nuclei/μl and kept at
15 °C until injected into oocytes at a flow rate of 0.6 μl/min over approximately
2 s.
Whole-mount in situ hybridization
WISH was performed as described in Harland (1991) and Hemmati-
Brivanlou et al. (1990).
309C.D. Rogers et al. / Developmental Biology 313 (2008) 307–319Bioinformatics
X. laevis sox3 genomic sequences were processed through RepeatMasker to
filter out interspersed repeat elements that can create false alignments (Smit and
Green, unpublished data; www.repeatmasker.org). Repeatmasker identified the
sequence from −790 to −429 bp as a portion of a PiggyBac-like DNA
transposon sequence.
Pairwise alignments were performed using both local and global alignment
algorithms, using the servers and tools freely available at the zPicture (Schwartz
et al., 2000) and Vista (Frazer et al., 2004) sites, respectively. Sequence
homology of consensus transcription factor binding elements was identified
using rVISTA (www.dcode.org), MatInspector (http://www.genomatix.de/) and
rankVista (www.genome.lbl.gov). To identify sequence conservation across
multi-species, sox3 genomic sequences were aligned and visualized using ECR
browser (www.dcode.org).
Results
Comparison of sox3 and sox2 expression in embryos and
ectodermal explants
X. laevis sox3 and sox2 are both expressed in the
presumptive neural ectoderm and CNS (Kishi et al., 2000;
Penzel et al., 1997; Nitta et al., 2006). To directly compare their
temporal and spatial expression patterns, we analyzed embryos
by RT-PCR (Fig. 1A) and whole mount in situ hybridization
(WISH) (Fig. 1B). Xenopus sox3 is maternally and zygotically
expressed and RT-PCR analysis demonstrates that sox3 levels
peak at stage 10–11, prior to the peak of sox2 expression at
stage 12–13 (Fig. 1A). WISH analysis further highlights the
differences in expression of sox3 and sox2. Like SOX3 in
chick, Xenopus sox3 is expressed initially throughout the
animal ectoderm and is later restricted to the dorsal ectoderm
(Penzel et al., 1997; Uwanogho et al., 1995). Sox3 expression
is stronger on the dorsal side by stage 10 and restricted to the
dorsal side by stage 11.5 (data not shown). In contrast, sox2
is first detectable by WISH at the onset of gastrulation (stage
10) in the dorsal ectoderm. As gastrulation proceeds
expression remains restricted to the presumptive neural
plate. During neurulation, both genes are expressed in the
neural tube and the otic placodes (Fig. 1B) (Schlosser and
Ahrens, 2004).
To characterize the expression of sox2 and sox3 in response
to BMP inhibition, we analyzed their expression in untreated
and noggin-injected animal ectodermal explants (caps, Fig. 1C,
Fig. S1). In untreated explants, sox3 and sox2 expression
pattern differs; sox3 mRNA is present from stage 8.5 until stage
11.5, while sox2 is not expressed. Both are induced in caps in
response to Noggin. Sox3 message is detectable through stage
17 and sox2 is expressed by stage 11.25 (data not shown) and
maintained through stage 17. This demonstrates that both are
induced in response to BMP inhibition.
FGF signaling is required for the maintenance of sox2 and
sox3 in ectodermal explants
We also analyzed the effect of Wnt and FGF signaling on
sox2 and sox3 expression in animal caps. We isolated animal
caps from embryos expressing proteins that inhibit signaling ofthe canonical Wnt (ΔTcf3, ΔXfz8) (Molenaar et al., 1996;
Sokol, 1996) or FGF pathways (XFD) (Amaya et al., 1991).
Expression of these dominant negative proteins in embryos
produced the expected results (Hardcastle et al., 2000; Roel
et al., 2002; Wallingford et al., 2001), however, they did not
alter expression of sox2 or sox3 in otherwise untreated animal
caps (data not shown). To determine if inhibition of Wnt or FGF
signaling interferes with the ability of Noggin to induce
expression of sox2 and 3, we analyzed expression in animal
caps from embryos injected with noggin in combination with
ΔTcf3, ΔXfz or XFD mRNA. Neither ΔTcf3 nor ΔXfz8 altered
sox3 or sox2 expression in response to Noggin (Fig. 2).
Notably, while no change was observed in gastrula stage
ectodermal explants injected with both noggin and XFD
mRNA, expression of both sox2 and sox3 was strongly reduced
by neurula stage (st. 17). These data indicate that FGF signaling
is required for the maintenance of early neural genes and that
neither Wnt nor FGF signaling is required for the induction of
sox2 or sox3 in animal caps.
The inhibition of sox3 by BMP and the induction of sox2 by
Noggin require de novo protein synthesis
We have shown that sox2 and sox3 expression is induced by
the inhibition of BMP in animal caps. To understand how
inhibition of BMP is translated into a transcriptional response,
we analyzed the effect of inhibiting protein synthesis on sox
expression (Fig. 3). Animal caps from uninjected and noggin-
injected embryos were cultured with the protein synthesis
inhibitor cycloheximide (CHX), collected at stages 10.5, 12.5
and 17 and then assayed for sox3 (Fig. 3A) or sox2 (Fig. 3B)
expression by WISH. To ensure that CHX-treated caps main-
tained high levels of BMP protein, we added exogenous BMP
protein to the media. Protein synthesis was effectively blocked
by CHX treatment as demonstrated by the absence of Xbra
expression and elongation of the animal caps from embryos
injected with activin mRNA (data not shown).
In CHX-incubated caps, sox3 mRNA was detectable from
stage 10.5 through stage 17 in the absence of Noggin and the
presence of exogenous BMP (Fig. 3A, columns 2 and 4).
Therefore, a BMP-responsive protein must be synthesized to
either degrade maternal sox3 message or to repress sox3
expression at stage 12.5. One possibility is that targets of BMP
signaling (e.g. Vent2 or Msx1) must be synthesized to repress
sox3. In contrast, sox2 is not expressed in uninjected caps
treated with CHX (Fig. 3B, column 2) and is not induced by
Noggin in the presence of CHX. Therefore, one interpretation is
that the inhibition of sox3 by BMP signaling requires the
synthesis of a repressor protein and it is derepressed in response
to neural induction while sox2 expression requires the synthesis
of an activator protein.
A 1.5-kb upstream regulatory fragment which is not conserved
across species recapitulates sox3 expression
To determine the mechanism by which the BMP signaling
pathway represses the induction of neural cell fates, we sought
Fig. 1. Comparison of sox3 and sox2 expression in whole embryos and ectodermal explants. (A) Temporal expression of sox3 and sox2 in whole embryos examined
by RT-PCR. ODC is used as a loading control. RT− is no reverse transcriptase and E is egg. (B) WISH analysis of sox3 and sox2 expression in cleavage (stage 6),
blastula (stage 9), gastrula (stage 10–12.5) and neurula (stage 18) embryos. Stage 6–10 embryos are viewed from the animal pole with dorsal to the right, stage 10.5
and 12.5 embryos from the vegetal pole with dorsal to the top, and stage 18 embryos from dorsal side with anterior to the top. The arrowhead and asterisk mark the
midline and otic placode, respectively. (C) Expression of sox3 and sox2 in animal ectodermal explants isolated from uninjected embryos and embryos injected with
noggin mRNA (indicated by +).
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in early gastrulae. The regulation of SOX2 has been studied
extensively in chick and the regulatory sequence is highly
conserved across species (Uchikawa et al., 2003). Therefore, we
chose to focus on the identification of modules required for
sox3 regulation and compare them to those previously identified
for sox2. Transgenic embryos containing a 1.5 kb sox3-GFP
reporter construct (Figs. 4A–F) were generated and analyzed by
WISH for GFP mRNA. WISH was used because the level of
GFP protein does not accumulate to detectable levels by the
gastrula stage and is difficult to detect due to the high level of
background autofluorescence. As expected, there was varia-
bility in the expression pattern likely due to the site of
integration and the transgene copy number. However, the
majority of transgenic embryos expressed GFP in the patterns
shown in Figs. 4A–F.
The sox3-GFP pattern recapitulates the endogenous sox3
expression pattern with some differences. In stage 10.5
transgenic embryos, GFP is expressed throughout the ectoderm
with higher levels in the dorsal ectoderm (Fig. 4A). By stage
12.5, GFP expression is restricted to the dorsal neuroectoderm
(Fig. 4B). Unlike endogenous sox3, GFP is expressed in the
ectoderm overlying the notochord and in the involutingmarginal zone adjacent to the blastopore indicating that a
module required for restriction of expression is missing. In early
tailbud embryos (stage 21 and stage 24), sox3-GFP is expressed
throughout the CNS and in the optic placodes but is missing
from the otic placodes (Figs. 4C and D). In late tailbud embryos,
like sox3, sox3-GFP is expressed in the CNS and developing
eyes (Fig. 4E). In stage 33 embryos, expression is strongest in
the lens epithelium, forebrain and midbrain (Fig. 4F). Addi-
tional regulatory sequences including the 5′ UTR and the 3′
UTR were tested in transgenic gastrula and neurula embryos
(data not shown) but they did not alter the expression pattern,
thus demonstrating they are not required for expression.
Strikingly, the 1.5 kb upstream regulatory fragment contains
most of the information necessary to recapitulate the spatial and
temporal expression of sox3. Importantly, the onset and
restriction of expression to the neuroectoderm occur at the
same time as endogenous sox3 allowing us to use this sox3-
GFP construct to identify cis-elements that respond to neural
induction and that are required for restriction of expression to
the neuroectoderm.
The recent publication of Xenopus tropicalis sox2 (Xtsox2)
and sox3 (Xtsox3) genomic sequence (www.jgi.org), allowed
comparison of the X. laevis and X. tropicalis sequences for
Fig. 2. FGF is required for the maintenance but not the induction of sox2 and sox3 expression in ectodermal explants. Expression of (A) sox3 and (B) sox2 in animal
ectodermal explants as revealed by WISH. Explants were excised between stages 8 and 9 from untreated embryos or those injected at the 1-cell stage with mRNA for
noggin alone, noggin plus ΔTCF3, noggin plus ΔXfz8 or noggin plus XFD mRNA. Explants were cultured until early gastrula (stage 10.5/11), late gastrula (stage
12.5) or neurula (stage 17) stage as determined by whole embryo controls.
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scription factor binding sites using zPicture and rVista (Loots
and Ovcharenko, 2004; Ovcharenko et al., 2004). In sequences
flanking Xtsox2, we identified 8 of the 11 ECRs shown to
regulate SOX2 expression in chick (Fig. S2A) (Uchikawa et al.,
2003). The ECRs downstream of Xtsox2 are in the same order
as in cSOX2. However, the region containing N2, NOP-1 and
N3 is inverted with respect to that region in avians. 56 bp of the
N1 enhancer (N1c) was shown to respond to Henson's node
signals and to contain a Wnt and FGF responsive region that is
required for expression in the posterior neural plate (Takemoto
et al., 2006). Interestingly, while N1c is present in X. tropicalis
with greater than 70% identity at approximately the same
location (13 kb downstream of sox2), only one of the two Lef
consensus binding sites required for response to Wnt is present
and the FGF responsive element is missing indicating that the
enhancer may not have the same role in Xenopus as it does in
chicken (Fig. S2B).
We next compared the regulatory region of Xlsox3 with that
of Xtsox3 and identified two highly conserved 500 bp blocks
that flank a 484 bp nonhomologous region (Fig. 4G). While theflanking sequences of Xtsox3 and Xlsox3 are highly conserved,
comparison of the ∼30 kb of X. tropicalis sequence with that of
mouse and human revealed only a few small blocks of
homology between the three species. Furthermore, none of
the sequences previously identified to be important for
expression of mSox3 were present (Brunelli et al., 2003) and
none of the cSOX2 ECRs was found in regions flanking Xtsox3.
Therefore, even though sox2 and sox3 are both induced in the
neuroectoderm in response to BMP inhibition and have
overlapping expression in the CNS, they do not have obvious
cis-modules in common.
Computational analysis revealed that the 1.5 kb fragment
that is sufficient to drive expression of X. laevis sox3 is not
conserved with species other than X. tropicalis. In fact, there is
little conservation between the flanking regions of X. tropicalis,
human and mouse sox3. Furthermore, the modules important
for cSOX2 are not present in the Xtsox3 surrounding sequence
and the modules conserved between Xtsox3 and Xlsox3 are not
in regions surrounding Xtsox2. These analyses indicate that the
modules that regulate sox2 are not conserved for sox3 and vice
versa.
Fig. 3. Sox3 inhibition by BMP and sox2 induction by Noggin require de novo protein synthesis. Expression of (A) sox3 and (B) sox2 in ectodermal explants revealed
by WISH. Explants were excised at stage 8–9 from untreated embryos or embryos injected with noggin mRNA at the 1-cell stage. Explants were incubated with or
without BMP protein and/or cycloheximide (CHX) as indicated at the top of each row. Explants were collected at early gastrula (stage 10.5), late gastrula (stage 12.5)
or neurula (stage 17) as indicated to the left. The whole embryo control by which the stage was determined is in the column on the far right.
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and restriction of sox3 expression
To identify cis-elements important for the onset and
restriction of sox3 expression, numerous 5′ end- and internal
deletions of sox3-GFP were constructed. These constructs
referred to as p2–p17 were used to generate transgenic early
and late gastrula (stage 10.5, 12–12.5, respectively) and/or
neurula (stage 17–20) embryos. The average transgenic
efficiency for sox3-GFP was 46% in gastrula and 57% in
neurula embryos. The total number of embryos (N) and the
number of transgenic embryos expressing GFP in gastrula and
neurula embryos (n) is presented in Table S1 for Fig. 5 and
Table 1 for Fig. 6.
Deletion analysis revealed that a regulatory fragment
extending to −746 bp upstream of the ATG (p2) is sufficient
to drive expression in the ectoderm of early gastrula embryos
and in the CNS of neurula embryos (Fig. 5A, Table S1). With
a slightly larger 5′ end-deletion which extends to −672 bp,
fewer embryos express GFP and those that do maintain a
much lower level of expression (p3, Fig. 5A, Table S1). As
expected, constructs with regulatory regions extending to
−520 bp and −299 bp also showed little expression (data not
shown). These results indicate that the region between −746
and −672 bp is necessary for expression. To confirm this, an
internal deletion of this region (p4) was generated and tested in
transgenic gastrula and neurula embryos. The majority of thep4 embryos showed no expression with only a few expressing
low levels of GFP (Fig. 5A, Table S1). This demonstrates that
p4, like p3, drives only very weak GFP expression and this is
due to the loss of an enhancer (A1) between −746 and −672 bp
(Fig. 5B).
To determine if A1 is sufficient to drive expression in the
ectoderm, fragments extending from −746 to −630 and −1047
to −630 bp were linked to the CSKA minimal promoter and
GFP and used to generate transgenic embryos (Fig. 5A, p11 and
p12). These transgenic embryos were assayed for expression by
WISH but only ∼10% expressed GFP weakly in the ectoderm
similar to that seen for P3 and p4 (Table S1). Therefore, the
region deleted in p3 and p4 (−746 to −672 bp) is necessary but
not sufficient for expression.
Larger internal deletions revealed a module required for
repression of expression. While the deletion between −746
and −672 (p4) resulted in a loss of expression, a larger
deletion from −746 to −520 (p5) resulted in expression in the
ectoderm of gastrula embryos. Furthermore, an even larger
deletion from −746 to −299 (p6) resulted in robust expression
throughout the ectoderm in the gastrula and neurula embryos
(Fig. 5A). One interpretation of these data is that a repressor
module (R1) lies between −672 bp and −299 bp and removal
of this repressor region abrogates the need for the A1 enhancer
(Fig. 5B). This indicates that a second enhancer module (A2)
is present between −746 and −1550 bp and is required for full
expression.
Fig. 4. A 1.55 kb Xlsox3 upstream regulatory region is partially conserved in X. tropicalis and mimics endogenous sox3 expression (A–F) WISH of transgenic
embryos expressing the Xlsox3-GFP reporter construct. (A) Vegetal view of a stage 10.5 and (B) stage 12 embryo with dorsal to the top. (C) Anterior view of a stage 21
embryo on top with a dorsal view of the same embryo directly below. (D) Lateral view of a stage 24 embryo with a dorsal view of the same embryo directly below. (E)
Dorsal view of a stage 27 embryo. (F) Lateral view of the head of a stage 33 embryo. The line represents the sox3 upstream regulatory region and −1.55 represents the
distance in kb from the ATG. The green box represents the EGFP coding region and the black box the SV40 polyA region. (G) Evolutionary conserved regions
between X. laevis and X. tropicalis sox3. A diagram of the sox3 regulatory region used in panels A–F is at the top with a percent identity plot (pip) of Xlsox3 aligned to
a homologous region of Xtsox3 below it. At the bottom is a pip of Xtsox3 aligned to Xlsox3. The blue box represents a 484-bp region in X. laevis which does not align
to the Xtsox3 sequence. The gray box represents a 30-bp region which is conserved between mouse and Xlsox3. The X-axis of the pip is the length of the sequence in
bases or kilobases as designated. The Y-axis spans 50–100% nucleotide identify with the light horizontal line in the center representing 75% nucleotide identity. The
red regions under the curve represent evolutionary conserved blocks. Two large blocks of the Xlsox3 upstream regulatory region align with Xtsox3. In Xtsox3, the first
block (farthest from the ATG) is split into two blocks.
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regulation of sox3-GFP
The upstream regulatory region of sox3 was analyzed to
identify transcription factor sites conserved with X. tropicalis.
Within A2 is an Elk-1 (Ets-like) consensus motif conserved
between X. laevis (−1495 bp) and X. tropicalis (−1274 bp)
(Dalton and Treisman, 1992; Rao and Reddy, 1992; Treis-
man et al., 1992) and a 30 bp direct repeat. However,
removal of the Elk site and direct repeat via a 200 bp 5′
deletion did not reduce expression levels (p17, 53%
expression in ectoderm, Table S1). A1 (green box, Fig.
6A) contains two adjacent forkhead binding sites (FKHD,
green text, Fig. 6A) with core sequences identical to the 7–
bp consensus site RTAAAYA (Kaufmann et al., 1995). These
sites were mutated in sox3-GFP and tested in transgenic
embryos (Fig. 6B). Mutation of the distal FKHD site (p13)led to a decrease in expression in neurula embryos (Fig. 6B).
Only 13% of the p13 embryos expressed GFP at low levels
in the anterior CNS compared to 31% of sox3-GFP embryos
expressing high levels of GFP throughout the CNS.
Mutation of the proximal FKHD site (p14) had no effect;
p14 embryos expressed high levels of GFP throughout the
CNS. Thus, the distal FKHD site is required for expression
of sox3-GFP in the CNS.
To further characterize the putative repressor module, R1
(−672 and −463 bp) was deleted leaving A1 intact to generate
construct p7 (Fig. 6C). Both p7 and p6 (A1 and R1 deleted) are
expressed throughout the ectoderm and are never restricted to
the neuroectoderm. While 92% of stage 12, sox3-GFP embryos
express GFP in only the dorsal ectoderm, 81% of p7 embryos
express GFP throughout the ectodermal tissue (Table 1). This
supports the hypothesis that the R1 is required for inhibition of
sox3 expression in non-neural ectoderm.
Fig. 5. A 74-bp region is required for expression of sox3-GFP. WISH for GFP
expression in gastrula (stage 10.5) and neurula (stage 17–20) transgenic
embryos containing sox3-GFP or deletions. (A) Diagrams of 5′ end and internal
deletions of the sox3 upstream regulatory region are labeled p1–6, 11, 12, 15
and 16. The region included in the construct is indicated by a bar and deletions
by the absence of this bar. A red bar denotes no expression of GFP, while a green
bar marks those constructs that drive GFP expression. Numbers indicate the
deletion end points with the left dashed vertical line marking 746 bp upstream of
the ATG and the right dashed line marking 672 bp upstream. (B) A model
summarizing the data. The region between −672 bp and −746 bp (green A2,
activator 2) is required for expression except when R1 (repressor module) is
deleted. In the absence of A2 and R1, a region between −746 bp and −1.55 kb
(A1) is required for expression. The total numbers of embryos with the
expression pattern shown and the relative levels of expression are in Table S1.
Table 1
Expression of GFP constructs during neural induction and neurulation
Figure Construct Stage N Pan-ectoderm
%
(n) Neuroectoderm
%
(n)
4A–F Sox3-GFP 10–10.5 104 77 (30) 23 (9)
11–11.5 138 52 (27) 48 (25)
12 44 8 (2) 92 (23)
6C p6 12 208 45 (40) 55 (48)
p7 12 51 81 (13) 19 (3)
p8 12 45 45 (10) 55 (12)
p9 12 62 47 (8) 53 (9)
p10 12 36 73 (16) 27 (6)
p10 17–20 71 68 (13) 32 (6)
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motif (Friedle et al., 1998) and one Vent2 half-site (Trindade
et al., 1999). Vent1 is a direct target of Vent2 (Friedle and
Knochel, 2002) which is a direct target of BMP signaling
(Rastegar et al., 1999) and both are expressed in the non-neural
ectoderm when sox3 is restricted to the neuroectoderm
(Gawantka et al., 1995; Onichtchouk et al., 1996). To determine
if these sites are important for restriction of sox3 expression, the
Vent1 consensus site was mutated to generate p8 and the Vent2
consensus site was deleted to generate p9. The sites were both
altered to generate p10 (Fig. 6C). While p8 and p9 transgenic
embryos expressed GFP in the dorsal ectoderm in late gastrula
embryos, p10 embryos expressed GFP throughout the ectoderm
in gastrula and neurula embryos (Fig. 6C). These deletion
studies demonstrate that a Vent1 and Vent2 consensus motif are
required for the restriction of sox3 expression to the
neuroectoderm.
Vent1 and Vent2 repress the expression of endogenous sox3 and
sox3-GFP in gastrula embryos
Transgenic analysis demonstrated that Vent consensus
binding sites are required for restriction of sox3 to the pre-
sumptive neural plate, thus supporting our interpretation of
CHX experiments that sox3 expression is inhibited by a target
of BMP. To determine if Vent1 or Vent2 alters the expression of
sox3-GFP, we injected 1-cell embryos with sox3-GFP DNA and
either vent1 (V1), vent2 (V2), or the dominant active VPvent1
(VPV1) or VPvent2 (VPV2) mRNA. As predicted, expression
of Vent1 or Vent2 decreased expression of sox3-GFP, and
VPV1 and VPV2 increased expression (Fig. 7A). To demon-
strate the two Vent consensus motifs are required for the Vent
proteins to alter expression, we injected the vent mRNAs (0.7 ng
vent1 and 3 ng vent2) with p10 DNA in which both Vent sites
are mutated (Fig. 7A). Overexpression of Vent1 or Vent2
mRNA had no effect on the expression of p10. Therefore, loss
of the two Vent consensus motifs in R1 prevents Vent1 or
Vent2 from repressing sox3-GFP expression.
We next asked whether Vent1 and/or Vent2 are required for
repression of endogenous sox3 expression by testing the effect
of overexpression of Vent1, Vent2, VPV1 or VPV2. Over-
expression of Vent1 and Vent2 resulted in inhibition of sox3 in
56% and 47% of the embryos, respectively (Fig. 7B). Some
cells expressing Vent proteins (as indicated by β-galactosidase
Fig. 6. Identification of transcription factor binding sites required for regulation of sox3-GFP expression. (A) Sequence of regulatory elements and putative
transcription factor binding sites. The boxed region is the putative activator module, A2, which is deleted in p4. The remaining sequence is the putative repressor
module, R1 which is deleted in p7. The entire region in A plus sequences up to −299 are deleted in p6. Putative forkhead (FKHD) binding sites are labeled in green and
putative Vent1 and Vent2 sites are in red. (B)WISH of transgenic embryos (stage 17–20) expressing sox3-GFP constructs. Embryos are a dorsal view with anterior to
the right. A diagram of the upstream regulatory region shown in A is on the left. The numbers in the lower right hand corner refer to the number of embryos with the
expression pattern shown over the total number of embryos. (C)WISH of transgenic embryos (stage 12) expressing sox3-GFP constructs. Embryos are a vegetal view
with dorsal to the top. An inverted triangle indicates a deletion and an X indicates that a site has been mutated. The total numbers of embryos with the expression
pattern shown are in Table 1. Putative TF sites from panel A are represented schematically in the same colors: green circle, Fkhd; red hexagon, Vent1 and Vent2.
315C.D. Rogers et al. / Developmental Biology 313 (2008) 307–319activity) also expressed sox3. These data suggest that while
Vent1 and 2 may be required for complete restriction of sox3
expression to the neuroectoderm, neither can repress sox3
expression entirely in the neural plate. One possibility is that
Vent function may require interaction with another protein. This
is supported by experiments in which the dominant activator
forms, VPV1 and VPV2, were overexpressed (Fig. 7B). Upon
binding the VPV proteins should effectively activate the
expression of target genes without this protein interaction.
Expression of either VPV protein resulted in an expansion ofsox3 in non-neural ectoderm in over 90% of late gastrula
embryos (Fig. 7B).
BMP inhibition induces sox3 expression in ectodermal
explants (Fig. 1C) and requires protein synthesis to repress
expression of sox3 (Fig. 3A). To determine if overexpression
of Vent1 or Vent2 inhibits the induction of sox3 by Noggin,
sox3 expression was analyzed in stage 12.5 ectodermal
explants from embryos injected with noggin and vent1 or
vent2 mRNA (Fig. 7C). Overexpression of Vent2 alone had no
effect, while overexpression of Vent1 slightly decreased the
Fig. 7. Vent1 and Vent2 repress sox3 and sox3-GFP expression. (A) Animal pole view of WISH for GFP in stage 12.5 embryos injected at the 1-cell stage with 50 pg
sox3-GFP DNA or p10 DNA (V1 and V2 sites mutated), lacZ mRNA as a tracer (light blue) and vent (V1), vent2 (V2), VPvent1 (VPV1) or VPvent2 (VPV2) mRNA.
(B)WISH of sox3 in stage 12.5 embryos injected with lacZ mRNA and vent mRNA as indicated. 1 of 32 cells was injected with V1 or V2 mRNA and 1 of 2 cells was
injected with VPV1 or VPV2 mRNA. Embryos are a dorsal view. The numbers in the right hand corner are the numbers of embryos with the same phenotype as that
shown over the total number of embryos. (C) RT-PCR using primers to sox3, geminin or ODC as a loading control of either uninjected ectodermal explants or those
injected with noggin, V1, V2, V1+V2, VPV1 and/or VPV2 mRNA.
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sox3. These responses in explants mimic those in whole
embryos with Vent1 decreasing sox3 expression more
effectively than Vent2. We also tested the response of gemi-
nin to the Vent proteins in explants since a geminin reporter
construct was shown to require Vent binding sites for
restriction of expression to the neuroectoderm (Taylor et al.,
2006). In this case, both Vent1 and Vent2 reduced geminin
expression in response to Noggin but neither VPV1 nor VPV2
induced expression.
Discussion
Many studies have investigated the signals required to
induce neural tissue in vertebrates. Yet, controversy remains
concerning the signaling pathways required and the combina-
tions of transcription factors necessary to activate expression
of early neural genes. Are FGF and Wnt signaling pathways
required for the regulation of early neural genes? How is
inhibition of BMP translated into a transcriptional response? Is
there a neurogenic code? We addressed these questions by
studying the regulation of the early neural gene sox3 and
comparing it to that of its paralog sox2. Here we show that
neither gene requires Wnt or FGF signaling for induction byBMP inhibition, but both require FGF signaling for the
maintenance of expression. In transgenic embryos we iden-
tified three cis-modules important for the regulation of sox3
expression. Through dissection of these modules, we uncover
evidence indicating that an unknown forkhead binding protein
is involved in the induction of sox3 and that two BMP targets,
Vent1 and Vent2 restrict expression of sox3 to the neuroecto-
derm. Surprisingly, none of these elements are conserved within
the sox2 locus.
FGF signaling is required for the maintenance of sox2 and
sox3 expression
Our studies indicate that FGF signaling is needed for the
maintenance of sox3 and sox2 expression (Fig. 2), however
both were induced by Noggin in explants when FGF signaling
through FGFR1 and 2 was inhibited. This differs from
previous work demonstrating that sox2 is not expressed in
whole embryos treated with the chemical FGF inhibitor
SU5402 (Delaune et al., 2005). SU5402 can inhibit the
tyrosine kinase activity of other FGF receptors (Grand et al.,
2004; Sun et al., 1999) and therefore the use of different
inhibitors may explain the discrepant results. Thus, together
these data indicate that while FGFR1 is not required for
317C.D. Rogers et al. / Developmental Biology 313 (2008) 307–319induction of sox2 and sox3 expression, other FGF signaling
pathways may be. An alternate possibility is that with excess
amounts of Noggin, inhibition of FGF signaling has no effect.
In this case, FGF signaling is required to inhibit Smad activity
and therefore BMP signaling (Pera et al., 2003) and this is
rendered nonessential in the presence of large quantities of
Noggin.
Inhibition of Wnt signaling with ΔTcf3 and ΔXfz8, did not
induce sox2 or sox3 expression in animal caps or affect their
expression in response to Noggin. However, recent studies
indicate that the early neural gene geminin requires the Wnt
pathway for expression in early gastrulae (Taylor et al., 2006).
While there are two TCF sites upstream of X. laevis sox3,
they are not required for expression of the sox3-GFP transgene
(p17, Table S1). Thus, distinct molecular mechanisms appear
to be used to induce sox3 and geminin expression in the
neuroectoderm.
Sox3 and sox2 are induced by Noggin in animal caps but have
different requirements for expression
Sox3 and sox2 have distinct spatiotemporal expression
patterns in ectodermal explants and in the early embryo. In
contrast to sox2, sox3mRNA is initially detected throughout the
ectoderm and in untreated explants of gastrula embryos. This
difference in expression could be due to maternal sox3 mRNA,
in which case, zygotic sox3 and sox2 expression could be
identical. However, our transgenic analysis of sox3 demon-
strates that sox3-GFP is initially expressed throughout the
ectoderm and gradually restricted to the neuroectoderm. Thus,
zygotic sox3 and sox2 are likely to have different patterns of
expression in the early gastrula embryo. Given this, different
mechanisms of regulation are expected.
Interestingly, CHX experiments provide further evidence
that distinct regulatory factors are required for sox2 and sox3
expression in response to BMP antagonism. One interpretation
is that a protein must be synthesized for sox2 to be expressed,
while sox3 is simply derepressed in neuroectoderm in response
to BMP inhibition and thus, does not require protein synthesis.
Comparisons of the sox2 and sox3 regulatory regions also
reveal differences; while Xenopus sox2 flanking sequences are
highly conserved with other vertebrates and contain modules
identified to be important for expression in the chick node,
Xenopus sox3 regulatory regions are not highly conserved
with Xenopus sox2 or even with sox3 across species other than
X. tropicalis. Thus, in toto, our experiments indicate that two
closely related genes have unique mechanisms of gene
regulation at the onset of neural development.
Vent proteins are required to restrict expression to the neural
ectoderm
Overexpression studies and deletion analyses in transgenic
embryos indicate that sox3 expression is restricted to the
neuroectoderm via the actions of the BMP target Vent2 and its
target Vent1 (Friedle and Knochel, 2002; Peiffer et al., 2005;
Rastegar et al., 1999). We present evidence that Vent1 andVent2 interact with the R1 enhancer to restrict sox3-GFP
expression to the neuroectoderm (Fig. 5C). In whole embryos,
Vent1 is most effective at reducing endogenous sox3 expression
in the neural plate and selectively reduces sox3 expression
in response to Noggin, in animal cap assays. However, both
VPVent1 and VPVent2 can induce sox3 expression in whole
embryos and animal caps.
Sox3 expression is dynamic; early pan-ectodermal expres-
sion is followed by gradual restriction to dorsal ectoderm. Our
findings, similar to those for the regulation of the early neural
gene zic1 (Tropepe et al., 2006), suggest that generation of this
complex pattern requires more than derepression from BMP
signaling. Indeed, analysis of deletion constructs in transgenic
embryos revealed an additional upstream module (A1) that is
necessary but not sufficient for expression of the sox3
transgene. Mutation of a forkhead consensus binding motif
within this module decreased expression in neurula embryos
with the exception of the anterior CNS. Since the mutation of
the forkhead binding site did not mimic the deletion of the A1
module, we suspect that additional elements within or upstream
of A1 are required for activity.
Conclusion
Our analyses of sox3 expression identified a module required
for restriction of expression to the neuroectoderm in late
gastrula and another required for expression in gastrula and
neurula embryos. These studies combined with animal cap
assays reveal that there are at least two other modules required
to control expression in gastrula embryos: (i) one to restrict
expression from the marginal zone and (ii) one to respond to
FGF signals to maintain expression in the neuroectoderm.
These studies when considered in light of previous studies of
SOX2 regulation in chick and our comparison of sox2 and
sox3 expression in frog, indicate that sox3 does not share the
same mechanism of regulation with sox2 or potentially even
across species. While conservation of regulatory modules is a
common way to identify important regulatory domains, the
absence of conserved transcription factor sites for genes with
similar expression profiles in different species is not unusual
(Dermitzakis and Clark, 2002). In fact, there are many other
genes which have different regulatory codes but maintain the
same expression profile (Ludwig et al., 2000). The question
remains: is there a neural transcription code? It would be
tempting to say “no” given the distinct regulation of sox2 and
sox3. Studies of the regulation of additional early neural
genes will help to elucidate this complex question of neural
development.
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